Abstract
Background: The HIT‐CRAD trial (ISRCTN57028065) is the first to combine home‐based non‐invasive brain stimulation with high‐volume strength and skill training over 8 weeks in patients with chronic radiation‐associated dysphagia (CRAD) following primary (chemo)radiotherapy for head and neck cancer. Methods: Fifty‐four patients were randomized into three groups. Group 1 performed 8 weeks of strength training. Groups 2 and 3 combined 4 weeks of strength training with 4 weeks of skill training. Group 3 received high‐definition transcranial direct current stimulation (HD‐tDCS) during training. Group 2 received sham HD‐tDCS. Results: Overall adherence and exercise adherence remained above 75% across all groups. Home‐based HD‐tDCS proved safe and feasible, with mild to moderate side effects (tingling, itching, or burning). Median exercise performance levels for strength training exercises ranged from 94% to 100%. Conclusions: This study confirms the feasibility of high‐volume strength and skill training with HD‐tDCS in patients with C‐RAD. Proactive adherence‐supporting factors facilitate high adherence in this population. Both real and sham HD‐tDCS proved safe, feasible, and well tolerated. Trial Registration: International Standard Randomized Controlled Trials Number (ISRCTN) registry ID ISRCTN57028065
Funding Information
  • Kom op tegen Kanker (KotK_KUL/2019/11813/1)

This publication has 28 references indexed in Scilit: